FSBC vs. AZN
FSBC (Five Star Bancorp) and AZN (AstraZeneca PLC) are both stocks. FSBC operates in Banks - Regional (Financial Services), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, FSBC returned 17.34%/yr vs 10.71%/yr for AZN. Their 0.12 correlation means their historical movements had little consistent relationship.
Performance
FSBC vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FSBC achieves a 34.39% return, which is significantly higher than AZN's -5.80% return.
FSBC
- 1D
- -0.11%
- 1M
- -3.02%
- 6M
- 21.37%
- YTD
- 34.39%
- 1Y
- 65.38%
- 3Y*
- 28.18%
- 5Y*
- 17.34%
- 10Y*
- —
- ALL TIME*
- 21.11%
AZN
- 1D
- -0.99%
- 1M
- -13.07%
- 6M
- -6.66%
- YTD
- -5.80%
- 1Y
- 17.91%
- 3Y*
- 8.37%
- 5Y*
- 10.71%
- 10Y*
- 12.78%
- ALL TIME*
- 12.63%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $431.89M | $497.68M | $403.88M | |
| $14.82M | $10.08M | $7.15M |
FSBC vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
FSBC Five Star Bancorp | 34.39% | 22.06% | 18.61% | -0.56% | -7.16% | 51.85% |
AZN AstraZeneca PLC | -5.80% | 43.30% | -0.62% | 1.44% | 19.14% | 9.32% |
Correlation
The correlation between FSBC and AZN is 0.15, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.15 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since May 4, 2021 | 0.12 |
Fundamentals
FSBC:
$1.01B
AZN:
$131.47B
FSBC:
$4.51
AZN:
$13.34
FSBC:
10.46
AZN:
12.71
FSBC:
5.01
AZN:
0.02
FSBC:
2.71
AZN:
2.16
FSBC:
$278.25M
AZN:
$61.18B
FSBC:
$168.04M
AZN:
$48.56B
FSBC:
$98.83M
AZN:
$20.49B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FSBC vs. AZN — Risk / Return Rank
FSBC
AZN
FSBC vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Five Star Bancorp (FSBC) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FSBC | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.72 | ||
| Sortino ratioReturn per unit of downside risk | +2.22 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.15 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 4.75 | 0.92 | +3.83 |
| Martin ratioReturn relative to average drawdown | 13.77 | 2.43 | +11.34 |
Loading charts...
Drawdowns
FSBC vs. AZN - Drawdown Comparison
The maximum FSBC drawdown since its inception was -40.76%, smaller than the maximum AZN drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for FSBC and AZN.
Loading charts...
Drawdown Indicators
| FSBC | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.76% | -48.94% | +8.18% |
Max Drawdown (1Y)Largest decline over 1 year | -13.07% | -21.08% | +8.01% |
Max Drawdown (3Y)Largest decline over 3 years | -24.54% | -27.87% | +3.33% |
Max Drawdown (5Y)Largest decline over 5 years | -40.76% | -27.87% | -12.89% |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.87% | — |
Current DrawdownCurrent decline from peak | -5.01% | -18.62% | +13.61% |
Average DrawdownAverage peak-to-trough decline | -12.98% | -11.39% | -1.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.50% | 7.99% | -3.49% |
Volatility
FSBC vs. AZN - Volatility Comparison
The current volatility for Five Star Bancorp (FSBC) is 6.62%, while AstraZeneca PLC (AZN) has a volatility of 11.83%. This indicates that FSBC experiences smaller price fluctuations and is considered to be less risky than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FSBC | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.62% | 11.83% | -5.21% |
Volatility (6M)Calculated over the trailing 6-month period | 14.75% | 19.94% | -5.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.44% | 27.24% | -1.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.38% | 24.51% | +6.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.61% | 24.96% | +7.65% |
Dividends
FSBC vs. AZN - Dividend Comparison
FSBC's dividend yield for the trailing twelve months is around 2.44%, less than AZN's 3.14% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 3.14% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
FSBC Five Star Bancorp | 2.44% | 2.24% | 2.66% | 2.86% | 2.20% | 1.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
FSBC vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Five Star Bancorp and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
FSBC vs. AZN - Profitability Comparison
FSBC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Five Star Bancorp reported a gross profit of 45.71M and revenue of 74.20M. Therefore, the gross margin over that period was 61.6%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, AstraZeneca PLC reported a gross profit of 11.18B and revenue of 15.19B. Therefore, the gross margin over that period was 73.6%.
FSBC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Five Star Bancorp reported an operating income of 26.09M and revenue of 74.20M, resulting in an operating margin of 35.2%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, AstraZeneca PLC reported an operating income of 3.07B and revenue of 15.19B, resulting in an operating margin of 20.2%.
FSBC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Five Star Bancorp reported a net income of 19.40M and revenue of 74.20M, resulting in a net margin of 26.1%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, AstraZeneca PLC reported a net income of 2.48B and revenue of 15.19B, resulting in a net margin of 16.3%.
Frequently Asked Questions
FSBC and AZN have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AZN has higher volatility (11.83%) compared to FSBC (6.62%). In terms of maximum drawdown, FSBC dropped -40.76% vs AZN's -48.94%.
FSBC currently has the higher Sharpe Ratio (2.45 vs 0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FSBC and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer